1. Home
  2. JZ vs VBIO Comparison

JZ vs VBIO Comparison

Compare JZ & VBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jianzhi Education Technology Group Company Limited

JZ

Jianzhi Education Technology Group Company Limited

N/A

Current Price

$1.02

Market Cap

1.1M

Sector

Real Estate

ML Signal

N/A

Logo Valion Bio Inc. Common Stock

VBIO

Valion Bio Inc. Common Stock

N/A

Current Price

$0.54

Market Cap

1.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JZ
VBIO
Founded
2011
2016
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
1.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
JZ
VBIO
Price
$1.02
$0.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 16.4M
313.0K
Earning Date
08-28-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $780,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.09
$0.12
52 Week High
$5.46
$812.50

Technical Indicators

Market Signals
Indicator
JZ
VBIO
Relative Strength Index (RSI) 54.11 21.43
Support Level $0.82 $0.12
Resistance Level $1.55 $4.39
Average True Range (ATR) 0.15 0.12
MACD -0.00 1.21
Stochastic Oscillator 28.90 1.63

Price Performance

Historical Comparison
JZ
VBIO

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has single operating segment: Educational content services and other services and IT-related solution services.

About VBIO Valion Bio Inc. Common Stock

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Share on Social Networks: